ALB and Huntington disease: In this study, molecular docking was utilized to examine the interactions between similar zwitterionic structures with different pendant groups (CBMA, SBMA, and MPC), both alone and in conjunction with PES, as ligands and the binding sites of the proteins (HSA, FB, TR) to determine the optimal ligand for use in HD therapy.